Yansong Lin
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study.
Journal: Frontiers in immunology
Published: June 07, 2025
Environmental exposure to perfluorooctane sulfonate and its role in esophageal cancer progression: a comprehensive bioinformatics and experimental study.
Journal: Scientific reports
Published: April 10, 2025
The prognostic value of the triglyceride-glucose index in predicting recurrence of acute pancreatitis: a retrospective cohort study.
Journal: Nutrition & metabolism
Published: March 11, 2025
Efficacy and safety outcomes of PD-1/PD-L1 inhibitors in recurrent cholangiocarcinoma: a real-world, multicenter and retrospective study.
Journal: BMC cancer
Published: March 05, 2025
ARL8B regulates lysosomal function and predicts poor prognosis in hepatocellular carcinoma.
Journal: Scientific reports
Published: November 15, 2024
Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe acute pancreatitis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 05, 2024
BIRC2 blockade facilitates immunotherapy of hepatocellular carcinoma.
Journal: Molecular cancer
Published: September 14, 2024
Inhibition of mitochondrial complex I induces mitochondrial ferroptosis by regulating CoQH2 levels in cancer.
Journal: Cell death & disease
Published: August 27, 2024
DAGLβ is the principal synthesizing enzyme of 2-AG and promotes aggressive phenotype of intrahepatic cholangiocarcinoma via AP-1/DAGLβ/miR4516 feedforward circuitry.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: June 27, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026